Artis Real Estate Investment Trust ("Artis" or the "REIT") announced that its trustees have declared a monthly cash ...

In Singapore, Dupixent is the first biologic medicine approved to treat these COPD patients. The prevalence of COPD is estimated to be around 6% of the general population [1], and it ranks as a ...

The acquisition of Aluna (also known as Knox Medical Diagnostics, Inc.), a leading U.S.-based company specializing in ...

Aspergillus is a fungus that can lead to life threatening infections of the lungs and blood stream called aspergillosis, ...

Blood type’s influence extends far beyond compatibility for blood donations, affecting the body through multiple biological ...

An investigative history of the scandal-plagued company shines a light on a health care industry riddled with corruption and ...

Discover 9 promising small molecule drug discovery companies that recently raised funding for their potentially breakthrough ...

TEMPO.CO, Jakarta - Tempo English compiled the top 3 news on Monday, May 12, 2025. Here are the highlights: Countries Beyond ...

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) announces that Guelph General Hospital in Canada will be the first in the country to add Sectra's digital pathology ...

The global COPD therapeutics market is on a robust growth trajectory, having achieved a market valuation of USD 12,144.1 million in 2023, and is projected to reach USD 20,035.5 million by 2033, ...

Niktimvo (axatilimab-csfr) is a first-in-class colony stimulating factor-1 receptor (CSF-1R)-blocking antibody approved for use in the U.S. for the treatment of chronic graft-versus-host disease (GVHD ...